Biotech | February 24, 2022
Aadi Bioscience launches Fyarro in the USA
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
The first wave of shipments includes several countries, such as Germany, France and Austria
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
New biotechnology product aims to be world's fastest automatic sanitary solution
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Appoints Dr Rafiq Hasan as CEO
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
Subscribe To Our Newsletter & Stay Updated
